Perrigo Company plc (NYSE:PRGO) Stock Holdings Raised by West Tower Group LLC

West Tower Group LLC lifted its position in Perrigo Company plc (NYSE:PRGO) by 174.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 101,992 shares of the company’s stock after buying an additional 64,766 shares during the quarter. Perrigo makes up approximately 5.7% of West Tower Group LLC’s portfolio, making the stock its 2nd biggest holding. West Tower Group LLC owned approximately 0.07% of Perrigo worth $2,675,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Foundry Partners LLC bought a new position in Perrigo during the third quarter valued at approximately $7,111,000. Invenomic Capital Management LP bought a new position in Perrigo during the first quarter valued at approximately $2,425,000. AQR Capital Management LLC grew its holdings in shares of Perrigo by 675.5% in the second quarter. AQR Capital Management LLC now owns 970,637 shares of the company’s stock worth $24,926,000 after purchasing an additional 845,470 shares during the last quarter. Tidal Investments LLC grew its holdings in shares of Perrigo by 423.8% in the first quarter. Tidal Investments LLC now owns 77,254 shares of the company’s stock worth $2,478,000 after purchasing an additional 62,504 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Perrigo by 3.8% in the second quarter. Allspring Global Investments Holdings LLC now owns 655,974 shares of the company’s stock worth $16,845,000 after purchasing an additional 23,835 shares during the last quarter. 95.91% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Perrigo news, Director Katherine C. Doyle sold 8,954 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $27.30, for a total transaction of $244,444.20. Following the completion of the transaction, the director now directly owns 6,009 shares of the company’s stock, valued at approximately $164,045.70. This trade represents a 59.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.40% of the stock is owned by company insiders.

Perrigo Stock Up 1.2 %

Shares of PRGO opened at $28.40 on Tuesday. The stock has a market capitalization of $3.87 billion, a price-to-earnings ratio of -24.27 and a beta of 0.48. Perrigo Company plc has a 1 year low of $23.89 and a 1 year high of $34.60. The business’s 50 day simple moving average is $25.99 and its 200-day simple moving average is $27.06. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.

Perrigo (NYSE:PRGO) last released its earnings results on Wednesday, November 6th. The company reported $0.81 earnings per share for the quarter, meeting the consensus estimate of $0.81. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.12 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.64 EPS. As a group, equities analysts expect that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Friday, November 29th will be given a $0.276 dividend. This represents a $1.10 annualized dividend and a dividend yield of 3.89%. The ex-dividend date of this dividend is Friday, November 29th. Perrigo’s payout ratio is currently -94.02%.

Wall Street Analysts Forecast Growth

PRGO has been the subject of a number of research analyst reports. StockNews.com raised Perrigo from a “hold” rating to a “buy” rating in a research note on Thursday, November 7th. Jefferies Financial Group reissued a “hold” rating and set a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a research report on Monday, September 23rd. Finally, Canaccord Genuity Group restated a “buy” rating and set a $42.00 price target on shares of Perrigo in a report on Monday, September 30th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.